Koers Biohaven Pharmaceutical Holding Company Ltd.
Aandelen
BHVN
VGG111961055
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
38,99 USD | -7,52% | -26,54% | -74,31% |
18/04 | Biohaven prijst $230 miljoen openbaar aanbod van aandelen | MT |
04/03 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. : HC Wainwright handhaaft koopadvies | ZM |
Omzet 2020 | 63,63 59,73 | Omzet 2021 | 462,51 434,17 | Marktkapitalisatie | 9,03 mld. 8,47 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -767 mln. -720 mln. | Nettowinst (verlies) 2021 | -847 mln. -795 mln. | EV/omzet 2020 | 87.534.473 x |
Nettoschuld 2020 | 432 mln. 406 mln. | Nettoschuld 2021 | 860 mln. 808 mln. | EV/omzet 2021 | 21.377.123 x |
K/w-verhouding 2020 |
-6,56
x | K/w-verhouding 2021 |
-10,5
x | Werknemers | 928 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 90,13% |
1 dag | -7,52% | ||
Lopende maand | -74,31% | ||
Lopend jaar | -74,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03-10-22 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25-10-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03-10-22 |
Gastón Ortega
BRD | Director/Board Member | - | 03-10-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.97% | 0 M€ | 0,00% | - | |
0.11% | 9 M€ | -.--% | - | |
0.06% | 736 M€ | +4,84% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 38,99 | -7,52% | 3 353 231 |
18-04-24 | 42,16 | -4,25% | 3 668 414 |
17-04-24 | 44,03 | +0,59% | 1 040 176 |
16-04-24 | 43,77 | -2,23% | 1 955 136 |
15-04-24 | 44,77 | -15,66% | 3 401 934 |
uitgestelde koers Nyse, 19 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-74,31% | 541 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |